Vilon is one of the smallest peptides studied in immunology research laboratories: a synthetic dipeptide composed of lysine and glutamic acid (Lys-Glu). Originally designed as a thymic peptide mimetic, it serves as a tool compound in preclinical immunology models, cell-differentiation studies, and analytical laboratories interested in ultra-short peptide characterization. This article covers its structure, how laboratories analyze it, and how it is used as a research model.
Molecular structure: a two-residue mimetic
With only two amino acid residues, Vilon represents the minimal end of the peptide complexity spectrum. Its structure — an N-terminal lysine linked by a single peptide bond to a C-terminal glutamic acid — makes it an attractive model for studying: (1) peptide bond stability in minimal systems, a clean test case for hydrolysis kinetics and degradation-pathway studies in aqueous buffers; (2) charge-state behavior, since both residues carry ionizable side chains, so laboratories exploit its pH-dependent charge shifts when developing ion-exchange and reversed-phase chromatographic methods; (3) structure–activity simplification, because the molecule is so small that any biological read-out in cell models can be discussed in direct terms of its two side chains, free of the conformational ambiguity of longer sequences.
Use as a research model in immunology laboratories
In preclinical research settings, Vilon has been investigated as a synthetic analogue of short thymic peptides. Laboratory studies use it in cell-culture models examining lymphocyte differentiation, cytokine-expression profiles, and gene-regulation readouts — always as a research tool for probing peptide-mediated signaling in vitro, never as a therapeutic candidate in these contexts. Its small size also makes it useful as a control compound in studies comparing di-, tri-, and tetrapeptide activity in immune-cell assays. Researchers value short peptides like Vilon for mechanistic work because they can be synthesized at high purity with minimal deletion-sequence impurities, simplifying the interpretation of cell-based experiments.
Analytical characterization of ultra-short peptides
Characterizing a dipeptide presents distinct analytical considerations: reversed-phase HPLC with ion-pairing or HILIC modes is typically required since dipeptides are highly polar and poorly retained on standard C18 phases; mass spectrometry (ESI-MS) confirms intact mass and detects trace synthesis byproducts such as the reversed sequence (Glu-Lys) or racemized forms; NMR spectroscopy provides definitive structural confirmation of the peptide bond and verifies the absence of cyclization side products; and elemental analysis and titration support counterion and salt-form determination, which matters for accurate preparation of cell-culture assay solutions. Because Vilon’s simplicity makes every impurity analytically visible, it is frequently cited in method-development papers as a benchmark analyte for short-peptide chromatography.
Why minimal peptides matter in research programs
Ultra-short peptides like Vilon occupy a useful niche: they are inexpensive to synthesize, easy to characterize to high purity, and straightforward to handle in screening workflows. For laboratories building peptide assay platforms, they provide a low-risk starting point before moving to complex, modified sequences.
References: Khavinson VK, et al. Peptide regulation of the genome and epigenome. Neuro Endocrinol Lett. 2014;35(1):1–8. Morozov VG, Khavinson VK. Natural and synthetic thymic peptides as means of maintenance of immune homeostasis. Biull Eksp Biol Med. 1997;123(4):455–460.
Disclaimer: All Vector Amino Labs products are sold strictly for laboratory research use only. Not for human consumption. This article is for informational purposes for qualified researchers and makes no medical, therapeutic, dosing, or efficacy claims.